This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG. Inherited predisposition to thrombosis. Cell. 1993; 72(4): 477-480.MiletichJPPrescottSMWhiteRMajerusPWBovillEG.Inherited predisposition to thrombosisCell199372447748010.1016/0092-8674(93)90063-VSearch in Google Scholar
Alfirevic Z, Simundic AM, Nikolac N, Sobocan N, Alfirevic I, Stefanovic M, et al. Frequency of factor II G20210A, factor V Leiden, MTHFR C677T and PAI-1 5G/4G polymorphism in patients with venous thromboembolism: Croatian case control study. Biochemia Medica. 2010; 20(2): 229-235.AlfirevicZSimundicAMNikolacNSobocanNAlfirevicIStefanovicMet al.Frequency of factor II G20210A, factor V Leiden, MTHFR C677T and PAI-1 5G/4G polymorphism in patients with venous thromboembolism: Croatian case control studyBiochemia Medica201020222923510.11613/BM.2010.028Search in Google Scholar
Segers K, Dahlback B, Gerry AFN. Coagulation factor V and thrombophilia: Background and mechanisms. Thromb Haemost. 2007; 98(3): 530-542.SegersKDahlbackBGerryAFN.Coagulation factor V and thrombophilia: Background and mechanismsThromb Haemost200798353054210.1160/TH07-02-0150Search in Google Scholar
Katcharin A, Napaporn A, Timaluck S, Pantep A. Prevalence of factor V Leiden (G1691A) and prothrombin gene mutation (G20210A) among different ethnic group in Thai hospitals. J Hematol Transfus Med. 2012; 22(2): 115-120.KatcharinANapapornATimaluckSPantepA.Prevalence of factor V Leiden (G1691A) and prothrombin gene mutation (G20210A) among different ethnic group in Thai hospitalsJ Hematol Transfus Med2012222115120Search in Google Scholar
Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C). Blood. 1995; 85(6): 1504-1508.RosendaalFRKosterTVandenbrouckeJPReitsmaPH.High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C)Blood19958561504150810.1182/blood.V85.6.1504.bloodjournal8561504Search in Google Scholar
Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA. 1997; 277(16): 1305-1307.RidkerPMMiletichJPHennekensCHBuringJE.Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screeningJAMA1997277161305130710.1001/jama.277.16.1305Search in Google Scholar
Herrmann FH, Koesling M, Schrŏder W, Altman R, Jiménez Bonilla R, Lopaciuk S, et al. Prevalence of factor V Leiden mutation in various population. Genet Epidemiol. 1997; 14(4): 403-411.HerrmannFHKoeslingMSchrŏderWAltmanRJiménez BonillaRLopaciukSet al.Prevalence of factor V Leiden mutation in various populationGenet Epidemiol199714440341110.1002/(SICI)1098-2272(1997)14:4<403::AID-GEPI5>3.0.CO;2-3Search in Google Scholar
Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996; 88(10): 3698-3703.PoortSRRosendaalFRReitsmaPHBertinaRM.A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosisBlood199688103698370310.1182/blood.V88.10.3698.bloodjournal88103698Search in Google Scholar
Bavikatty N, Kileen A, Akel N, Normolle D, Schmaier A. Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American population. Am J Clin Pathol. 2000; 114(2): 272-275.BavikattyNKileenAAkelNNormolleDSchmaierA.Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American populationAm J Clin Pathol2000114227227510.1309/LQKG-F0D4-C6FF-FNEHSearch in Google Scholar
Tosetto A, Missiaglia E, Frezzato M, Rodeghiero F. The VITA project: C677T mutation in the methylene-tetrahydofolate reductase gene and risk of venous throm-boembolism. Br J Haematol. 1997; 97(4): 804-806.TosettoAMissiagliaEFrezzatoMRodeghieroF.The VITA project: C677T mutation in the methylene-tetrahydofolate reductase gene and risk of venous throm-boembolismBr J Haematol199797480480610.1046/j.1365-2141.1997.1422957.xSearch in Google Scholar
den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis. N Engl J Med. 2005; 3(2): 292-299.den HeijerMLewingtonSClarkeR.Homocysteine, MTHFR and risk of venous thrombosisN Engl J Med200532292299Search in Google Scholar
Karic A, Terzic R, Jerkic Z, Mustedanagic-Mujanovic J. The frequency of C677T methylentetra-hidrofolate reductase (MTHFR) polymorphism in Southern East Bosnian population. J Biomet Biostat. 2013; 4(4): 1-4.KaricATerzicRJerkicZMustedanagic-MujanovicJ.The frequency of C677T methylentetra-hidrofolate reductase (MTHFR) polymorphism in Southern East Bosnian populationJ Biomet Biostat20134414Search in Google Scholar
Adler G, Agnieszka G, Valjevac A, Czerska E, Kiseljakovic E, Salkic N. Prevalence of genetic prothrombotic risk factors: 1691G>A FV, 20210G>A PT and 677 C>T MTHFR mutations in Bosnian population. Ann Hum Biol. 2014; 42(6): 576-580.AdlerGAgnieszkaGValjevacACzerskaEKiseljakovicESalkicN.Prevalence of genetic prothrombotic risk factors: 1691G>A FV, 20210G>A PT and 677 C>T MTHFR mutations in Bosnian populationAnn Hum Biol201442657658010.3109/03014460.2014.968618Search in Google Scholar
Bertina RM, Koelman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation facto V associated with resistance to activated protein C. Nature. 1996; 369(6475): 64-67.BertinaRMKoelmanBPKosterTRosendaalFRDirvenRJde RondeHet al.Mutation in blood coagulation facto V associated with resistance to activated protein CNature19963696475646710.1038/369064a0Search in Google Scholar
Froost P, Blom HJ, Milos R, Gazette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylene-tetrahydrofolatereductase. Nat Genet. 1995; 10(1): 111-113.FroostPBlomHJMilosRGazettePSheppardCAMatthewsRGet al.A candidate genetic risk factor for vascular disease: A common mutation in methylene-tetrahydrofolatereductaseNat Genet199510111111310.1038/ng0595-111Search in Google Scholar
McHugh M. The odds ratio: Calculation, usage and inerpretation. Biochemia Medica. 2009; 19(2): 120-126.McHughM.The odds ratio: Calculation, usage and inerpretationBiochemia Medica200919212012610.11613/BM.2009.011Search in Google Scholar
Kejzer M, den Hajer M, Blom HJ, Bos GMJ, Willems HPJ, Gerrits WBJ, et al. Interaction between hyperhomocysteinemia, mutated methylenetetra-hydrofolate reductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost. 2002; 88(5): 72-78.KejzerMden HajerMBlomHJBosGMJWillemsHPJGerritsWBJet al.Interaction between hyperhomocysteinemia, mutated methylenetetra-hydrofolate reductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosisThromb Haemost20028857278Search in Google Scholar
Meglic L, Stegnar M, Milanez T, Bozic M, Peterlin B, Peternel P, et al. Factor V Leiden, prothrombin 20210 G>A, methylenetetrahydro-folate reductase 677C>T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy related venous thromboembolism. Eur J Obstet Gynecol Reprod Biol. 2003; 111(2): 157-163.MeglicLStegnarMMilanezTBozicMPeterlinBPeternelPet al.Factor V Leiden, prothrombin 20210 G>A, methylenetetrahydro-folate reductase 677C>T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy related venous thromboembolismEur J Obstet Gynecol Reprod Biol2003111215716310.1016/S0301-2115(03)00212-4Search in Google Scholar
Berge E, Haug KB, Sandset EC, Haughbro KK, Turkovic M, Sandset PM. The factor V Leiden, prothrombin gene 20210GA, methylenetetra-hydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ishemic stroke and atrial fibrillation. Stroke. 2007; 38(3): 106-171.BergeEHaugKBSandsetECHaughbroKKTurkovicMSandsetPM.The factor V Leiden, prothrombin gene 20210GA, methylenetetra-hydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ishemic stroke and atrial fibrillationStroke200738310617110.1161/01.STR.0000258076.04860.8eSearch in Google Scholar
Pauer H, Voigt-Tschirschwitz T, Hinney B, Burfeind P, Wolf C, Emons G, et al. Analyzes of three common thrombophilic gene mutations in German women with recurrent abortions. Acta Obstet Gynecol Scand. 2003; 82(10): 942-947.PauerHVoigt-TschirschwitzTHinneyBBurfeindPWolfCEmonsGet al.Analyzes of three common thrombophilic gene mutations in German women with recurrent abortionsActa Obstet Gynecol Scand2003821094294710.1034/j.1600-0412.2003.00293.xSearch in Google Scholar
Koster T, Roosendal FR, de Ronde H, Riet E, Vandenbroucke JP, Bertina R. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilila study. Lancet. 1993; 342(8886-8887): 1503-1506.KosterTRoosendalFRde RondeHRietEVandenbrouckeJPBertinaR.Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilila studyLancet19933428886-88871503150610.1016/S0140-6736(05)80081-9Search in Google Scholar
Coen D, Zadro R, Honovic, Banfic Lj, Rukavina-Stavljenic A. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism. Croat Med J. 2001; 42(4): 488-492.CoenDZadroRHonovic, BanficLjRukavina-StavljenicA.Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolismCroat Med J2001424488492Search in Google Scholar
Đorđevic V, Rakicevic Lj, Mikovic D, Kovac M, Miljic P, Radojkovic D, et al. Prevalence of factor V Leiden, factor V Cambridge, factor II G20210A and methylenetetra-hydrofolatere-ductase C677T mutations in healthy and thrombophilic Serbian populations. Acta Haematol. 2004; 112(4): 227-229.ĐorđevicVRakicevicLjMikovicDKovacMMiljicPRadojkovicDet al.Prevalence of factor V Leiden, factor V Cambridge, factor II G20210A and methylenetetra-hydrofolatere-ductase C677T mutations in healthy and thrombophilic Serbian populationsActa Haematol2004112422722910.1159/00008128015564739Search in Google Scholar
Arsov T, Miladinova D, Spiroski M. Factor V Leiden is associated with higher risk deep venous thrombosis of large blood vessels. Croat Med J. 2006; 47(3): 433-439.ArsovTMiladinovaDSpiroskiM.Factor V Leiden is associated with higher risk deep venous thrombosis of large blood vesselsCroat Med J2006473433439Search in Google Scholar
Jadaon MM. Epidemiology of prothrombin G20210A mutation in the Mediterranean region. Mediterr J Hematol Infect Dis. 2011; 3(1): e2011054. doi: 10.4084/MJHID.2011.054.JadaonMM.Epidemiology of prothrombin G20210A mutation in the Mediterranean regionMediterr J Hematol Infect Dis201131e2011054doi10.4084/MJHID.2011.054324833122220251Open DOISearch in Google Scholar
Isotalo PA, Donnely JG. Prevalence of methylenetetra-hydrofolatereductase mutations in patients with venous thrombosis. Mol Diagn. 2000; 5(1): 59-66.IsotaloPADonnelyJG.Prevalence of methylenetetra-hydrofolatereductase mutations in patients with venous thrombosisMol Diagn200051596610.2165/00066982-200005010-00013Search in Google Scholar
Moglinicka-Nizankowska E, Adamek L, Grzanka P, Domagala TB, Sanak M, Krzanowski M, et al. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis. Eur Respir J. 2003; 21(1): 25-30.Moglinicka-NizankowskaEAdamekLGrzankaPDomagalaTBSanakMKrzanowskiMet al.Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosisEur Respir J2003211253010.1183/09031936.03.0003430212570104Search in Google Scholar
D’Angelo A, Beltramentti C. Venous disease. In: Carmel R, Jacobsen DW, Eds. Homocysteine in Health and Disease. Cambridge, Cambridgeshire, UK: Cambridge University Press. 2001:401-414.D’AngeloABeltramenttiC.Venous diseaseCarmelRJacobsenDWHomocysteine in Health and DiseaseCambridge, Cambridgeshire, UKCambridge University Press2001401414Search in Google Scholar
Tsai AW, Cushman M, Tsai MY, Heckbert SR, Rosamond WD, Aleksic N, et al. Serum homocysteine, thermolabile variant of methylenetetra-hydrofolat reductase (MTHFR) and venous thromboembolism: Longitudinal investigation of thromboembolism etiology (LITE). Am J Hematol. 2003; 72(3): 192-200.TsaiAWCushmanMTsaiMYHeckbertSRRosamondWDAleksicNet al.Serum homocysteine, thermolabile variant of methylenetetra-hydrofolat reductase (MTHFR) and venous thromboembolism: Longitudinal investigation of thromboembolism etiology (LITE)Am J Hematol200372319220010.1002/ajh.1028712605391Search in Google Scholar
Beyan C, Beyan E. MTHFR 677 CT gene polymorphism is not a risk factor for venous thromboembolism. Çukurova Med J. 2014; 39(1): 189-190.BeyanCBeyanE.MTHFR 677 CT gene polymorphism is not a risk factor for venous thromboembolismÇukurova Med J2014391189190Search in Google Scholar
Ehrenforth S, von Fepka-Prondsinski M, Aygoren-Pursun E, Nowak-Gottl U, Scharrer I, Ganser A. Study of the prothrombin gene 20210GA variant in FV:Q506 car-riers in the relationship to the presence or absence of juvenile venous thromboemolism. Arterioscler Thromb Vasc Biol. 1999; 19(2): 276-280.EhrenforthSvon Fepka-ProndsinskiMAygoren-PursunENowak-GottlUScharrerIGanserA.Study of the prothrombin gene 20210GA variant in FV:Q506 car-riers in the relationship to the presence or absence of juvenile venous thromboemolismArterioscler Thromb Vasc Biol199919227628010.1161/01.ATV.19.2.2769974407Search in Google Scholar
Zoller B, Svanson PJ, He X, Dahlback B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest. 1994; 94(6): 2521-2524.ZollerBSvansonPJHeXDahlbackB.Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein CJ Clin Invest19949462521252410.1172/JCI1176233300877989612Search in Google Scholar
Ferraresi P, Marchetti G, Legnani C, Cavallari E, Castoldi E, Mascoli F, et al. The heterozygous 20210G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilia and is not increased in frequency of artery disease. Arterioscler Thromb Vasc Biol. 1997; 17(11): 2418-2422.FerraresiPMarchettiGLegnaniCCavallariECastoldiEMascoliFet al.The heterozygous 20210G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilia and is not increased in frequency of artery diseaseArterioscler Thromb Vasc Biol199717112418242210.1161/01.ATV.17.11.2418Search in Google Scholar
De Stefano V, Martinelli I, Mannuccio P, Paciaroni K, Chiusolo P, Casorelli I, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med. 1999; 341(11): 801-806.De StefanoVMartinelliIMannuccioPPaciaroniKChiusoloPCasorelliIet al.The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutationN Engl J Med19993411180180610.1056/NEJM19990909341110410477778Search in Google Scholar
Simone B, De Stefano V, Leoncini E, Zacho, Martinelli I, Emmerich J, et al. Risk of venous thromboembolism associated with single and combined effects of factor V Leiden, prothrombin 20210A and methylenetetra-hydrofolate reductase C677T: A meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol. 2013; 28(8): 621-647.SimoneBDe StefanoVLeonciniEZacho, MartinelliIEmmerichJet al.Risk of venous thromboembolism associated with single and combined effects of factor V Leiden, prothrombin 20210A and methylenetetra-hydrofolate reductase C677T: A meta-analysis involving over 11,000 cases and 21,000 controlsEur J Epidemiol201328862164710.1007/s10654-013-9825-8393523723900608Search in Google Scholar
